Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and PK of Transderm Scop in Healthy Adults
NCT03029650Phase 4Completed
- Sponsor
- University of Iowa
- Start
- Nov 2016
- Primary completion
- Apr 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of scopolamine in motion sickness, sponsored by University of Iowa. Started Nov 2016; status: completed.
02
Drugs
scopolamine
03
Conditions
motion sickness
Beyond the preview
Go deeper on NCT03029650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03029650.